| __timestamp | Walgreens Boots Alliance, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 54823000000 | 1717000000 |
| Thursday, January 1, 2015 | 76585000000 | 1738000000 |
| Friday, January 1, 2016 | 87477000000 | 1666000000 |
| Sunday, January 1, 2017 | 89052000000 | 1775000000 |
| Monday, January 1, 2018 | 100745000000 | 1911000000 |
| Tuesday, January 1, 2019 | 91915000000 | 1992000000 |
| Wednesday, January 1, 2020 | 95905000000 | 2057000000 |
| Friday, January 1, 2021 | 104442000000 | 2303000000 |
| Saturday, January 1, 2022 | 104437000000 | 2454000000 |
| Sunday, January 1, 2023 | 112009000000 | 2710000000 |
| Monday, January 1, 2024 | 121134000000 |
Infusing magic into the data realm
In the ever-evolving landscape of the pharmaceutical and retail sectors, Zoetis Inc. and Walgreens Boots Alliance, Inc. stand as titans. From 2014 to 2023, Walgreens Boots Alliance has seen a steady increase in its cost of revenue, peaking at approximately 112 billion in 2023, a 104% rise from 2014. This reflects the company's expansive growth and operational scaling. In contrast, Zoetis Inc., a leader in animal health, has experienced a more modest increase, with its cost of revenue growing by about 58% over the same period, reaching nearly 2.71 billion in 2023. This divergence highlights the distinct market dynamics and strategic priorities of these industry leaders. Notably, data for 2024 is incomplete, offering a glimpse into the challenges of forecasting in a volatile market. As these companies navigate the future, their cost management strategies will be pivotal in maintaining competitive advantage.
Cost Insights: Breaking Down Novo Nordisk A/S and Walgreens Boots Alliance, Inc.'s Expenses
Cost Insights: Breaking Down Bristol-Myers Squibb Company and Zoetis Inc.'s Expenses
Cost of Revenue: Key Insights for Zoetis Inc. and BeiGene, Ltd.
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Corcept Therapeutics Incorporated
Cost Insights: Breaking Down Zoetis Inc. and Vericel Corporation's Expenses
Cost of Revenue Comparison: Zoetis Inc. vs Travere Therapeutics, Inc.
Cost Insights: Breaking Down Viatris Inc. and Walgreens Boots Alliance, Inc.'s Expenses
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Alkermes plc's Expenses
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: Walgreens Boots Alliance, Inc. and Mesoblast Limited